SOD2 expression is decreased in the pulmonary vasculature of PPHN human infants, as well as in the lamb model (122), contributing to endothelial dysfunction and impaired NO-dependent vasodilation (122). Here, SOD2 is linked to persistent fetal circulation syndrome.